NCT06547775View on ClinicalTrials.gov

A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight

PHASE1RecruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 2, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

June 30, 2027

Conditions

Overweight or Obesity

Interventions

DRUG

KN069

Solution for SC injection

Trial Locations (1)

Unknown

RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Suzhou Alphamab Co., Ltd.

INDUSTRY